As an example, in breast cancer patients, peptide vaccination using the E75 peptide in combination with GM-CSF in breast cancer patients was able to activate both naïve CD4+ T cells as well as memory-phenotype CD4+ T cells specific for the tumor. Here, CSF2 is linked to breast carcinoma.